Likely related to the rapid proliferative capacity of this tumor, the VRP-FLT3 vaccine was unable to completely eliminate the tumor, and there was no survival benefit observed with either VRP-FLT3 or VRP-Ctrl vaccination (Supplementary Figure 4A). Here, FLT3 is linked to neoplasm.